HealthEquity, Inc - HQY STOCK NEWS

HealthEquity, Inc. (NASDAQ: HQY) announced a successful partnership with Pfizer to enhance diversity, equity, and inclusion (DEI) in employee benefits. The innovative HSA plan categorizes employees into four income tiers, providing the highest contributions to lower income earners. This approach led to over one-third of eligible employees enrolling in the HSA plan, with 37% from the lowest income tier. The initiative addresses the needs of all employees, aiming to improve healthcare access and long-term financial wellbeing while affirming the significance of benefits in driving DEI advancements.

HealthEquity (NASDAQ: HQY) reported strong third-quarter results, achieving revenue of $216.1 million, up 20% year-over-year. The net loss narrowed to $1.6 million, compared to $5.0 million in Q3 FY22, with non-GAAP net income rising to $32.4 million, a 12% increase. The company recorded Adjusted EBITDA of $73.4 million, also up 20%. HealthEquity's HSAs increased to 7.7 million, a 23% growth. For FY23, management projects revenue between $850 million and $860 million, with a net loss guidance of $34 million to $27 million.

HealthEquity, the largest HSA custodian in the US, announced the release of its third quarter fiscal 2023 financial results on December 6, 2022. Following the announcement, management will host a conference call at 4:30 p.m. ET to discuss the results. The company partners with employers and benefits advisors to serve over 14 million accounts, focusing on connecting health and wealth.

For further details, visit www.healthequity.com.

Thomas H. Lee Partners announced the appointment of Paul Black as a consultant for its healthcare investment group. With over 25 years in healthcare IT, Black will assist in identifying and growing investment opportunities. His past roles include CEO of Allscripts (MDRX) and COO of Cerner (CERN). Shahab Vagefi, Managing Director at THL, emphasized Black's experience will enhance their strategy focused on healthcare technology investments. THL has raised over $34 billion and has a history of successful healthcare investments.

HealthEquity (HQY) reported a Q2 FY23 revenue of $206.1 million, a 9% increase from $189.1 million in Q2 FY22. However, the company incurred a net loss of $10.7 million, compared to a loss of $3.8 million in the same quarter last year. Non-GAAP net income decreased by 16% to $28.1 million, with earnings per diluted share of $0.33, down from $0.40. Adjusted EBITDA rose 2% to $67.0 million. The company saw 7.5 million HSAs, a 26% increase year-over-year, and total HSA assets grew 33% to $20.5 billion.

HealthEquity, Inc. (HQY) announced the election of Paul M. Black to its Board of Directors, enhancing the board to 12 members, 10 of whom are independent. Black brings over 25 years of executive experience, previously serving as CEO of Allscripts Healthcare Solutions. His expertise in healthcare IT is expected to contribute significantly to HealthEquity's mission to connect health and wealth for American families. Black will participate in both the Audit and Risk Committee and the Talent, Compensation and Culture Committee, signaling a focus on governance and corporate culture.

HealthEquity (NASDAQ: HQY) announced the release of its Q2 fiscal 2023 financial results set for September 6, 2022, after market close. Management will discuss these results during a conference call at 4:30 p.m. ET on the same day. Investors can register for the call online. Additionally, HealthEquity will participate in two upcoming investor conferences in September, presenting at the Wells Fargo Healthcare Conference on September 7 and the RW Baird Global Healthcare Conference on September 13. More than 14 million accounts are administered by HealthEquity through its HSA services.